Cyclica and CheminPharma have partnered to develop a pipeline of macrocycle therapeutics to modulate challenging targets, especially protein-protein interactions identified as important for treating certain cancers.

This pipeline will be developed by Abacus Therapeutics, which will seek independent financing and co-development partnerships with pharmaceutical companies.

more